Pharma-Bio Serv Inc (PBSV): The trailing PE is now a little over 4 w...

Reply Private New

Replies (1) Next 10 Prev Next

Send PM Follow Ignore

Followers	556
Posts	17586
Boards Moderated	4
Alias Born	01/02/2005

MikeDDKing

Re: None

Friday, 06/15/2012 9:41:35 AM

Friday, June 15, 2012 9:41:35 AM

The trailing PE is now a little over 4 with the latest quarterly earnings of $0.052/share. They now have nine sequential quarters of increasing revenue. This is a great company!

Mike

SwingTrade is my favorite board - #board-1781

Due diligence on my favorite stocks is located on the sticky note on the SwingTrade board.

Keep Last Read

Replies (1) Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

Detailed Quote

Recent PBSV News

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend] • Edgar (US Regulatory) • 02/28/2024 09:29:23 PM
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 01/29/2024 09:56:41 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/13/2024 02:09:01 AM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/13/2024 02:07:27 AM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/13/2024 02:06:25 AM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/10/2024 01:34:22 AM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/10/2024 01:16:44 AM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/28/2023 09:23:58 PM
Form 8-K - Current report • Edgar (US Regulatory) • 12/21/2023 01:43:37 PM
Form 8-K - Current report • Edgar (US Regulatory) • 09/14/2023 09:19:19 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 09/14/2023 08:16:34 PM

More PBSV News

InvestorsHub NewsWire

NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM

ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM

Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM

Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM

Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM

Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM

Start posting your company's news

Only $200 per official company press release!

Volume
Day Range:
Bid Price
Ask Price
Last Trade Time:

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover